FITC anti-mouse CD206 (MMR) Antibody
- 产品名称：
- FITC anti-mouse CD206 (MMR) Antibody
- 产品类别：
- 抗体
- 产品编号：
- 141703
- 产品应用：
- 141703
- Verified Reactivity
- Mouse
- Antibody Type
- Monoclonal
- Host Species
- Rat
- Immunogen
- Recombinant mouse CD206 (MMR)
- Formulation
- Phosphate-buffered solution, pH 7.2, containing 0.09% sodium azide.
- Preparation
- The antibody was purified by affinity chromatography, and conjugated with FITC under optimal conditions.
- Concentration
- 0.5 mg/ml
- Storage & Handling
- The antibody solution should be stored undiluted between 2°C and 8°C, and protected from prolonged exposure to light. Do not freeze.
- Application
-
ICFC - Quality tested
FC - Verified
- Recommended Usage
Each lot of this antibody is quality control tested by intracellular immunofluorescent staining with flow cytometric analysis. For flow cytometric staining, the suggested use of this reagent is ≤0.125 ?g per million cells in 100 ?l volume. It is recommended that the reagent be titrated for optimal performance for each application.
- Excitation Laser
- Blue Laser (488 nm)
- Application Notes
Clone C068C2 recognizes a region similar to clone MR5D3, based on the ability of the clones to block each other. Additional reported applications (for the relevant formats) include: spatial biology (IBEX)4,5.
- Application References
(PubMed link indicates BioLegend citation) -
- Keller J, et al. 2012. Biochem Biophys Res Commun. 417:217. PubMed
- Ito H, et al. 2012. J Am Soc Nephrol. 23:1797. PubMed
- Yang X, et al. 2015. PNAS. 112:2900. PubMed
- Radtke?AJ,?et al.?2020.?Proc Natl Acad Sci U S A.?117:33455-65. (SB)?PubMed
- Radtke?AJ,?et al.?2022.?Nat Protoc.?17:378-401. (SB)?PubMed
- Product Citations
-
- Oliver AJ, et al. 2020. Oncoimmunology. 9:1802979. PubMed
- Sun L, et al. 2021. Cancer Cell. :. PubMed
- Liang S, et al. 2019. Mol Med Rep. 19:3707. PubMed
- Valanparambil RM, et al. 2017. PLoS Pathog. 13:e1006647. PubMed
- Meng W, et al. 2021. JCI Insight. 6:. PubMed
- Keane T, et al. 2012. Biomaterials. 33:1771. PubMed
- Miao L, et al. 2020. Theranostics. 0.7625. PubMed
- Kesavan R, et al. 2021. Int J Mol Sci. 22:. PubMed
- Zakeri A, et al. 2021. J Extracell Vesicles. 10:e12131. PubMed
- Choi B, et al. 2017. Eur J Pharmacol. 10.1016/j.ejphar.2017.07.022. PubMed
- Song C, et al. 2019. Nat Commun. 10:3745. PubMed
- Li C, et al. 2022. Theranostics. 12:4581. PubMed
- Ma C, et al. 2022. Proc Natl Acad Sci U S A. 119:. PubMed
- Zhang W, et al. 2021. Front Immunol. 12:688294. PubMed
- Wada I, et al. 2021. Invest Ophthalmol Vis Sci. 62:17. PubMed
- Eastman A, et al. 2016. J Immunol . 194: 5999-6010. PubMed
- Lee S, et al. 2015. PLoS One. 10: 0132329. PubMed
- Hindi S, et al. 2012. Mol Cell Biol. 32:4833. PubMed
- Wu R, et al. 2019. J Cell Mol Med. 24:1684. PubMed
- Song M, et al. 2021. J Immunol Res. 6696606:2021. PubMed
- Uroda T, et al. 2020. Nat Protoc. 15:2107. PubMed
- Li H, et al. 2019. J Immunol Res. 2018:4807145. PubMed
- Li K, et al. 2022. J Immunother Cancer. 10:. PubMed
- Yang Y, et al. 2022. Regen Biomater. 9:rbac023. PubMed
- Forni MF, et al. 2021. Front Oncol. 11:667715. PubMed
- Ma J, et al. 2021. Curr Protoc. 1:e144. PubMed
- Shin JE, et al. 2021. Heliyon. 7:e08433. PubMed
- Amo-Aparicio J, et al. 2021. Theranostics. 11:9805. PubMed
- Li Z, et al. 2022. J Exp Clin Cancer Res. 41:74. PubMed
- Guo L, et al. 2021. Front Immunol. 12:785457. PubMed
- Nguyen TKT, et al. 2020. Am J Pathol. 286:190. PubMed
- Yin S, et al. 2016. Nat Commun. 7: 11311. PubMed
- Yin T, et al. 2016. Sci Rep. 18:19534. PubMed
- Linde N, et al. 2018. Nat Commun. 9:21. PubMed
- Shi R, et al. 2022. Theranostics. 12:875. PubMed
- Lee SS, et al. 2022. Commun Biol. 5:654. PubMed
- Vigeland C, et al. 2016. PLoS One. 11: 0163288. PubMed
- Lu CS, et al. 2020. J Hematol Oncol. 0.584722222. PubMed
- Li N, et al. 2021. eLife. 10:00. PubMed
- Neupane AS, et al. 2020. Cell. 183(1):110-125.e11. PubMed
- Zhang F, et al. 2017. Mol Immunol. 10.1016/j.molimm.2017.06.019. PubMed
- Lin S, et al. 2022. Nat Commun. 13:3301. PubMed
- Sun L, et al. 2015. J Immunol. 194:4891. PubMed
- Kida Y, et al. 2013. J Am Soc Nephrol. 24:559. PubMed
- Wang W, et al. 2018. Oncogenesis. 7:97. PubMed
- Xie Z, et al. 2018. J Am Heart Assoc. 7:e007442. PubMed
- Ishii H, et al. 2012. Cell Death Dis. 9;3:e363. PubMed
- Wang T, et al. 2018. Front Physiol. 9:209. PubMed
- Lu J, et al. 2021. Cell Death Discov. 7:165. PubMed
- Tomay F, et al. 2019. J Transl Med. 17:237. PubMed
- Zhou T, et al. 2022. Sci Adv. 8:eabj9617. PubMed
- Guan X, et al. 2022. Nat Commun. 13:2834. PubMed
- Yang Y, et al. 2020. Cancer Biol Ther. 522:21. PubMed
- Galle-Treger L, et al. 2019. Nat Commun. 10:713. PubMed
- Genoula M, et al. 2018. Front Immunol. 9:459. PubMed
- Zimmerman KA, et al. 2019. J Am Soc Nephrol. 30:1841. PubMed
- Miki Y, et al. 2022. JCI Insight. 7:. PubMed
- Zhang S, et al. 2022. Nat Commun. 13:4744. PubMed
- Shibata T, et al. 2020. J Clin Invest. 130:3021. PubMed
- Li Y, et al. 2015. Sci Rep. 5: 18648. PubMed
- Ano Y, et al. 2019. Nutrients. 1.959027778. PubMed
- Makino A, et al. 2021. iScience. 24:103201. PubMed
- Wang S, et al. 2022. J Inflamm Res. 14:7107. PubMed
- Liu Y, et al. 2015. BioMed Res Int. 2015 563425. PubMed
- Shen L, et al. 2016. Sci Rep. 6:30347. PubMed
- Cuccarese M, et al. 2017. Nat Commun. 8:14293. PubMed
- Yuan Y, et al. 2020. Front Physiol. 0.967361111. PubMed
- Laban H, et al. 2018. J Cell Biol. 217:1503. PubMed
- Wang X, et al. 2021. Cell. 184:5357. PubMed
- de Assis LVM, et al. 2022. Commun Biol. 5:461. PubMed
- Kaji T, et al. 2012. J Exp Med. 80:3642. PubMed
- Grayczyk JP et al. 2017. Cell host & microbe. 22(5):678-687 . PubMed
- Wang D, et al. 2021. Nan Fang Yi Ke Da Xue Xue Bao. 41:775. PubMed
- Zhang A, et al. 2021. Theranostics. 11:3839. PubMed
- Madsen CS, et al. 2022. Commun Biol. 5:888. PubMed
- Wang S, et al. 2020. J Cell Mol Med. 24:722. PubMed
- Yoshida H, et al. 2019. Cell. 176:897. PubMed
- McAusland TM, et al. 2021. Mol Ther Oncolytics. 20:306. PubMed
- Medina-Buelvas DM, et al. 2021. Pathogens. 10:. PubMed
- Gao R, et al. 2021. J Clin Invest. 131:. PubMed
- Chen Y, et al. 2021. Cancer Cell. 39(4):548-565.e6. PubMed
- Xue YL, et al. 2020. J Cell Mol Med. 24:12341. PubMed
- Zhang J, et al. 2014. J Immunol. 193:5149. PubMed
- Fransén Pettersson N, et al. 2018. PLoS One. 13:e0203228. PubMed
- Hartwig T et al. 2017. Molecular cell. 65(4):730-742 . PubMed
- Gu L, et al. 2017. FASEB J. 31:3072. PubMed
- Perrotta C, et al. 2018. Front Immunol. 9:1186. PubMed
- Chen Z, et al. 2016. Innate Immunity. 22: 419 - 432. PubMed
- Hall JA, et al. 2020. Cell Metabolism. 32(4):665-675.e6. PubMed
- Wu L, et al. 2020. Cancer Immunol Res. 710:8. PubMed
- Kim YD, et al. 2020. J Cancer. 11:4059. PubMed
- Scheyltjens I, et al. 2022. Nat Protoc. 17:2354. PubMed
- Xue Y, et al. 2020. Sci Rep. 10:22265. PubMed
- Kapralov AA, et al. 2020. Nat Chem Biol. 278:16. PubMed
- Li J, et al. 2021. eLife. 10:00. PubMed
- Xiang W, et al. 2020. Signal Transduct Target Ther. 0.374305556. PubMed
- Yao Y, et al. 2016. Mol Ther. 10.1038/mt.2016.36. PubMed
- Kim SH, et al. 2020. Neoplasia. 1.3375. PubMed
- Yuan C, et al. 2020. Braz J Med Biol Res. 53:e9488. PubMed
- RRID
- AB_10900988 (BioLegend Cat. No. 141703) AB_10901166 (BioLegend Cat. No. 141704)
- Structure
- Type I transmembrane protein, 175 kD, C-type lectin superfamily
- Distribution
-
Macrophages, dendritic cells, Langerhans cells, liver endothelial cells
- Function
- Pathogen recognition, endocytosis and phagocytosis, antigen presentation
- Ligand/Receptor
- Antigen containing mannose, fucose, or an N-acetyl glucosamine
- Cell Type
- Dendritic cells, Endothelial cells, Langerhans cells, Macrophages
- Biology Area
- Cell Biology, Immunology, Innate Immunity, Signal Transduction
- Molecular Family
- CD Molecules
- Antigen References
-
1. Wileman TE, et al. 1986. P. Natl. Acad. Sci. USA 83:2501.
2. Apostolopoulos V, et al. 2001. Curr. Mol. Med. 1:469.
3. Burgdorf S, et al. 2006. J. Immunol. 176:6770.
4. McKenzie EJ, et al. 2007. J. Immunol. 178:4975.
- Gene ID
- 17533 View all products for this Gene ID
- UniProt
- View information about CD206 on UniProt.org
